![]() |
Trials |
Niraparib and/or Niraparib-bevacizumab combination against bevacizumab alone in Women with platinum-sensitive epithelial ovarian, fallopian tube, or primary peritoneal cancer Part 1: AVANOVA1 and part 2: AVANOVA2Cancer type: Ovarian cancer Phase: I Principal Investigator: Mirza Mansoor Raza Country: DK Keywords: Denmark, Rigshospitalet, PARP-inhibitor + bevacizumab, Status: Inclusion completed Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT02354131?term=niraparib&rank=1 |